Category: Press Releases

Bitdeer AI Accelerates Global AI Cloud Expansion with NVIDIA GB200 NVL72 Deployment

Bitdeer AI Accelerates Global AI Cloud Expansion with NVIDIA GB200 NVL72 Deployment Leave a reply SINGAPORE, Jan. 14, 2026 (GLOBE NEWSWIRE) — Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider and NVIDIA Cloud Partner, today announced the launch of its NVIDIA GB200 NVL72 deployment in

Attindas Hygiene Partners Expands European Position with Key Acquisition

Attindas Hygiene Partners Expands European Position with Key Acquisition Leave a reply RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners’ growth strategy realized an important step forward today with its acquisition of Societá Italiana Lavorazione Cellulosa (SILC S.p.A.). Attindas executed a share purchase agreement with SILC, acquiring

Attindas Hygiene Partners Expands European Position with Key Acquisition

RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners’ growth strategy realized an important step forward today with its acquisition of Societá Italiana Lavorazione Cellulosa (SILC S.p.A.). Attindas executed a share purchase agreement with SILC, acquiring all shares of the 53-year-old, family-owned company. SILC S.p.A. serves customers throughout

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine Leave a reply WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine Leave a reply WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of